Experienced in Anemia

Dr. Sherif S. Farag

Hematology | Oncology
Community Physicians Of Indiana Inc
3500 S Lafountain St, 
Kokomo, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
35 Years of Experience
Experienced in Anemia
Community Physicians Of Indiana Inc
3500 S Lafountain St, 
Kokomo, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sherif Farag is a Hematologist and an Oncologist in Kokomo, Indiana. Dr. Farag has been practicing medicine for over 35 years and is rated as an Experienced provider by MediFind in the treatment of Anemia. His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant. Dr. Farag is currently accepting new patients.

His clinical research consists of co-authoring 57 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Anemia.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in IN
Hospital Affiliations
Community Howard Regional Health Inc.
Community Hospital Of Anderson And Madison County
Community Hospital North
Community Hospital East
Languages Spoken
English
Arabic
Arabic - Jordanian
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

COMMUNITY PHYSICIANS OF INDIANA INC
3500 S Lafountain St, Kokomo, IN 46902

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Enrollment Status: Recruiting
Publish Date: April 17, 2025
Intervention Type: Drug
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Enrollment Status: Completed
Publish Date: January 23, 2024
Intervention Type: Drug
Study Drugs: CD24Fc, Methotrexate, Tacrolimus
Study Phase: Phase 2
A Randomized, Double Blind, Placebo Controlled, Multi-center, Phase III Study of CD24Fc for Prevention of Acute Graft-Versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
A Randomized, Double Blind, Placebo Controlled, Multi-center, Phase III Study of CD24Fc for Prevention of Acute Graft-Versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Enrollment Status: Terminated
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drugs: CD24Fc, Methotrexate, Tacrolimus
Study Phase: Phase 3
A Phase I Study of Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease (SR-aGVHD) or Treatment-refractory Acute Graft-versus-host Disease (TR-aGVHD)
A Phase I Study of Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease (SR-aGVHD) or Treatment-refractory Acute Graft-versus-host Disease (TR-aGVHD)
Enrollment Status: Completed
Publish Date: January 19, 2023
Intervention Type: Biological
Study Drug: Neihulizumab (AbGn-168H)
Study Phase: Phase 1
A Phase II Trial of Prostaglandin E2 Inhibition, Using Meloxicam, Plus Filgrastim for Mobilization of Autologous Peripheral Blood Stem Cells in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
A Phase II Trial of Prostaglandin E2 Inhibition, Using Meloxicam, Plus Filgrastim for Mobilization of Autologous Peripheral Blood Stem Cells in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
Phase II Trial of Inhibition of Dipeptidyl Peptidase (DPP)-4 With Sitagliptin for the Prevention of Acute Graft Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Phase II Trial of Inhibition of Dipeptidyl Peptidase (DPP)-4 With Sitagliptin for the Prevention of Acute Graft Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter Phase II Trial of Inhibition of CD26 Peptidase Using Sitagliptin to Enhance Engraftment After Umbilical Cord Blood Transplantation for Adults With Hematological Malignancies
A Multicenter Phase II Trial of Inhibition of CD26 Peptidase Using Sitagliptin to Enhance Engraftment After Umbilical Cord Blood Transplantation for Adults With Hematological Malignancies
Enrollment Status: Completed
Publish Date: January 08, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

57 Total Publications

Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.
Journal: Transplantation
Published: June 23, 2025
Similar Doctors
Distinguished in Anemia
Dr. Jonathan L. Berkowitz
Oncology | Hematology | Hematology Oncology
Distinguished in Anemia
Dr. Jonathan L. Berkowitz
Oncology | Hematology | Hematology Oncology

Indiana University Health Ball Memorial Physicians Inc

2401 W University Ave, 
Muncie, IN 
 (41.3 miles away)
765-747-3111
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Jonathan Berkowitz is an Oncologist and a Hematologist in Muncie, Indiana. Dr. Berkowitz is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Vitamin B12 Deficiency Anemia, Folate Deficiency, Multiple Carboxylase Deficiency, and Thrombocytopenia. Dr. Berkowitz is currently accepting new patients.

Distinguished in Anemia
Dr. Edmond Bendaly
Hematology | Oncology
Distinguished in Anemia
Dr. Edmond Bendaly
Hematology | Oncology

Marion General Hospital

831 N Theatre Dr, 
Marion, IN 
 (24.9 miles away)
765-660-7800
Languages Spoken:
English
See accepted insurances

Edmond Bendaly is a Hematologist and an Oncologist in Marion, Indiana. Dr. Bendaly is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Midline Lethal Granuloma, and Thrombocytopenia.

Distinguished in Anemia
Dr. Pavan M. Ravella
Hematology | Oncology
Distinguished in Anemia
Dr. Pavan M. Ravella
Hematology | Oncology

Arnett Clinic, LLC

2600 Greenbush St, 
Lafayette, IN 
 (38.9 miles away)
765-448-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pavan Ravella is a Hematologist and an Oncologist in Lafayette, Indiana. Dr. Ravella is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Thrombocytopenia, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Neuroendocrine Tumor. Dr. Ravella is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Farag's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 14 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile